Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
October 14, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
August 23, 2024
Predetermined Change Control Plans (PCCPs) for Medical Devices: FDA Issues Draft Guidance
November 21, 2024
Kristen Fournier counsels Johnson & Johnson before a Texas federal court in a class action dispute over the bankruptcy plan of the company
November 19, 2024
King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York